Mass Spectrometry-Based De Novo Sequencing of Monoclonal Antibodies Using Multiple Proteases and a Dual Fragmentation Scheme
peer-reviewed · Journal of Proteome Research · 2021
peer-reviewed · Journal of Proteome Research · 2021. Weiwei Peng et al. Antibody sequence information is crucial to understanding the structural basis for antigen binding and…
| Date | 2021-07-02 |
| Type | peer-reviewed |
| Venue | Journal of Proteome Research |
| Publisher | American Chemical Society (ACS) |
| Contribution | downstream-application |
| DOI | 10.1021/acs.jproteome.1c00169 |
| Citations (OpenAlex) | 68 |
| Venue 2-year citedness | 3.83 |
Preprint version: Mass spectrometry-based de novo sequencing of the anti-FLAG-M2 antibody using multiple proteases and a dual fragmentation scheme (2021-01-08, bioRxiv)
Abstract
Antibody sequence information is crucial to understanding the structural basis for antigen binding and enables the use of antibodies as therapeutics and research tools. Here, we demonstrate a method for direct de novo sequencing of monoclonal IgG from the purified antibody products. The method uses a panel of multiple complementary proteases to generate suitable peptides for de novo sequencing by liquid chromatography-tandem mass spectrometry (LC-MS/MS) in a bottom-up fashion. Furthermore, we apply a dual fragmentation scheme, using both stepped high-energy collision dissociation (stepped HCD) and electron-transfer high-energy collision dissociation (EThcD), on all peptide precursors. The method achieves full sequence coverage of the monoclonal antibody herceptin, with an accuracy of 99% in the variable regions. We applied the method to sequence the widely used anti-FLAG-M2 mouse monoclonal antibody, which we successfully validated by remodeling a high-resolution crystal structure of the Fab and demonstrating binding to a FLAG-tagged target protein in Western blot analysis. The method thus offers robust and reliable sequences of monoclonal antibodies.
Methods and tools
- Multi-protease dual-fragmentation antibody sequencing: Direct de novo sequencing of monoclonal IgG from the purified product with a panel of complementary proteases and both stepped HCD and EThcD on every precursor, demonstrated on the anti-FLAG-M2 antibody.
Data used
- Anti-FLAG-M2 antibody sequencing (as deposited) · PXD023419
Cites (8)
- Database-independent Protein Sequencing (DiPS) Enables Full-length de Novo Protein and Antibody Sequence Determination (2017) both
- Automated Antibody De Novo Sequencing and Its Utility in Biopharmaceutical Discovery (2017) both
- De Novo MS/MS Sequencing of Native Human Antibodies (2017) both
- Complete De Novo Assembly of Monoclonal Antibody Sequences (2016) both
- Combining phage display with de novo protein sequencing for reverse engineering of monoclonal antibodies (2016) both
- Primary sequence determination of a monoclonal antibody against α-synuclein using a novel mass spectrometry-based approach (2012) both
- Resurrection of a clinical antibody: Template proteogenomic de novo proteomic sequencing and reverse engineering of an anti‐lymphotoxin‐α antibody (2011) both
- Automated de novo protein sequencing of monoclonal antibodies (2008) both
Cited by (41)
- Mass Spectrometry-Based De Novo Sequencing of N-Glycosylated Light Chains: Linking Urinary Proteoforms to In Situ Renal Amyloid Deposits (2026) both
- Reference-free protein sequencing by consensus assembly of redundant de novo peptide reads (2026) both
- Mass Spectrometry-based Antibody Sequencing Technologies (2026) both
- Deep coverage and extended sequence reads obtained with a single archaeal protease expedite de novo protein sequencing by mass spectrometry (2026) both
- Generalizable Direct Protein Sequencing With InstaNexus (2026) both
- AbNovoBench: a resource and benchmarking platform for monoclonal antibody de novo sequencing (2026) both
- Systematic benchmarking of mass spectrometry-based antibody sequencing reveals methodological biases (2025) both
- Bidirectional Representations Augmented Autoregressive Biological Sequence Generation (2025) semanticscholar
- Structural Basis for Postfusion-Specific Binding to the Respiratory Syncytial Virus F Protein by the Canonical Antigenic Site I Antibody 131–2a (2025) both
- Generalizable direct protein sequencing with InstaNexus (2025) crossref
- Do-It-Yourself De Novo Antibody Sequencing Workflow that Achieves Complete Accuracy of the Variable Regions (2025) crossref
- Simultaneous polyclonal antibody sequencing and epitope mapping by cryo electron microscopy and mass spectrometry (2025) crossref
- Epitope and Paratope Mapping of a SUMO-Remnant Antibody Using Cross-Linking Mass Spectrometry and Molecular Docking (2025) both
- Decoding Protein Glycosylation by an Integrative Mass Spectrometry-Based De Novo Sequencing Strategy (2025) both
- Systematic benchmarking of mass spectrometry-based antibody sequencing reveals methodological biases (2024) crossref
- Enhancing De Novo Protein Sequencing through the C-Terminal Labeling Strategy: Resolving Isobaric Ambiguities by Electron-Transfer/Higher Energy Collision Dissociation (EThcD) (2024) crossref
- De novo protein sequencing of antibodies for identification of neutralizing antibodies in human plasma post SARS-CoV-2 vaccination (2024) both
- Transforming de novo peptide sequencing by explainable AI (2024) crossref
- A Handle on Mass Coincidence Errors in De Novo Sequencing of Antibodies by Bottom-up Proteomics (2024) both
- Immunoglobulin repertoire sequencing and de novo sequencing – Powerful tools for identifying free light chains from patients with light chain cast nephropathy (2024) crossref
- Improved detection of tryptic immunoglobulin variable region peptides by chromatographic and gas-phase fractionation techniques (2024) both
- Reverse-engineering the anti-MUC1 antibody 139H2 by mass spectrometry–based de novo sequencing (2024) both
- NovoLign: metaproteomics by sequence alignment (2024) crossref
- de Novo Sequencing of Antibodies for Identification of Neutralizing Antibodies in Human Plasma Post SARS-CoV-2 Vaccination (2024) both
- NovoLign: metaproteomics by sequence alignment (2024) both
- Deep learning-driven fragment ion series classification enables highly precise and sensitive de novo peptide sequencing (2024) both
- Into the Dark Serum Proteome: Personalized Features of IgG1 and IgA1 Repertoires in Severe COVID-19 Patients (2024) both
- Direct Mass Spectrometry-Based Detection and Antibody Sequencing of Monoclonal Gammopathy of Undetermined Significance from Patient Serum: A Case Study (2023) both
- Reverse engineering the anti-MUC1 hybridoma antibody 139H2 by mass spectrometry-based de novo sequencing (2023) both
- Antibody proteomics (2023) crossref
- Comprehensive evaluation of peptide de novo sequencing tools for monoclonal antibody assembly (2023) both
- Deep learning-driven fragment ion series classification enables highly precise and sensitive de novo peptide sequencing (2023) crossref
- A perspective toward mass spectrometry-based de novo sequencing of endogenous antibodies (2022) both
- No patient is the same; lessons learned from antibody repertoire profiling in hospitalized severe COVID-19 patients (2022) semanticscholar
- De novo assisted AFB1-Specific monoclonal antibody sequence assembly and comprehensive molecular characterization (2022) crossref
- Template-Based Assembly of Proteomic Short Reads For De Novo Antibody Sequencing and Repertoire Profiling (2022) both
- Current state, existing challenges, and promising progress for de novo sequencing and assembly of monoclonal antibodies (2022) semanticscholar
- Template-Assisted De Novo Sequencing of SARS-CoV-2 and Influenza Monoclonal Antibodies by Mass Spectrometry (2022) crossref
- Template-based assembly of proteomic short reads for de novo antibody sequencing and repertoire profiling (2022) crossref
- Human plasma IgG1 repertoires are simple, unique, and dynamic (2021) both
- De Novo Sequencing of Antibody Light Chain Proteoforms from Patients with Multiple Myeloma (2021) both